Glenmark and Bausch Health join hands to commercialise RYALTRIS nasal spray in Canada ...Middle East

Devdiscourse - Opinion
Glenmark and Bausch Health join hands to commercialise RYALTRIS nasal spray in Canada
Mumbai (Maharashtra) [India], March 22 (ANI/PRNewswire): Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical company, today announced that its subsidiary Glenmark Specialty S.A. in Switzerland and an affiliate of Bausch Health Companies Inc. have entered into an exclusive licensing agreement for the commercialization of Glenmark's innovative nasal spray RYALTRIS under review by Health Canada. Under the terms of the agreement, Glenmark will be responsible for regulatory approvals and supply of RYALTRIS for the Canadian market. Bausch Health, Canada will be responsible for the commercialization of RYALTRIS in the Canadian market, following regulatory approval. Glenmark w

Hence then, the article about glenmark and bausch health join hands to commercialise ryaltris nasal spray in canada was published today ( ) and is available on Devdiscourse ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Glenmark and Bausch Health join hands to commercialise RYALTRIS nasal spray in Canada )

Apple Storegoogle play

Last updated :

Also on site :